Congestion clinical trials

Explore recruiting congestion clinical trials.

Recruiting congestion studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Congestion trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized Phase 2, double-blind, placebo-controlled, parallel-group, 2-arm study to assess the efficacy, safety, and tolerability of subcutaneous lunsekimig in adult participants with chronic rhinosinusitis with nasal polyps (CRSwNP)

Bulgaria, Poland, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, double blind, placebo controlled, parallel group, 52­week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps

Poland, Denmark, France, Romania, Netherlands, Germany +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy and safety trial of intraperitoneal furosemide in patients on peritoneal dialysis

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Acetazolamide in combination with SGLT2i in patients with volume overload and acute heart failure

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Participants with Chronic Rhinosinusitis Without Nasal Polyps – The BiRCh Study

Bulgaria, Czechia, Denmark, Spain, Portugal, Belgium +5 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, double blind, placebo controlled, parallel group, 52­week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps

Sweden, Portugal, Germany, Poland, Hungary, Netherlands +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Congestion trials by city

Congestion in Toronto Congestion in Vancouver Congestion in Montreal Congestion in Calgary Congestion in Edmonton Congestion in Ottawa Congestion in Winnipeg Congestion in Quebec City Congestion in Hamilton Congestion in Kitchener Congestion in London Congestion in Halifax Congestion in New York Congestion in Los Angeles Congestion in Chicago Congestion in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease